← FDA DRUG APPROVALS

FDA ANDA · ANDA070980

POTASSIUM CHLORIDE

Sponsor: NESHER PHARMS

APPLICATION
ANDA070980
TYPE
ANDA
ORIGINAL APPROVAL
1987-02-17
LATEST ACTION
2002-03-13
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 10MEQ · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

2002-03-13Manufacturing (CMC) · Supplement 26AP
2000-11-30Manufacturing (CMC) · Supplement 20AP
2000-11-30Manufacturing (CMC) · Supplement 19AP
2000-11-30Labeling · Supplement 21AP
2000-09-25Manufacturing (CMC) · Supplement 22AP
1999-03-04Manufacturing (CMC) · Supplement 18AP
1998-06-30Manufacturing (CMC) · Supplement 17AP
1993-04-16Manufacturing (CMC) · Supplement 14AP
1992-12-22Manufacturing (CMC) · Supplement 12AP
1992-08-19Manufacturing (CMC) · Supplement 13AP
1992-02-28Manufacturing (CMC) · Supplement 10AP
1992-02-28Labeling · Supplement 11AP
1992-02-28Manufacturing (CMC) · Supplement 9AP
1991-12-06Manufacturing (CMC) · Supplement 6AP
1991-02-28Labeling · Supplement 8AP
1991-02-15Manufacturing (CMC) · Supplement 7AP
1990-05-25Manufacturing (CMC) · Supplement 5AP
1989-12-22Manufacturing (CMC) · Supplement 2AP
1989-12-22Labeling · Supplement 3AP
1987-02-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →